Open AccessNeoadjuvant Immunotherapy May Change Breast Cancer Care Standard
Author(s) -
Peter M. Goodwin
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000615224.74719.61
Subject(s) - breast cancer , medicine , pembrolizumab , oncology , taxane , anthracycline , triple negative breast cancer , chemotherapy , cancer , immunotherapy